Roche Holding | ROG - Interest Expense On Debt

Stock Price
374.00
Daily Change
3.60 0.97%
Monthly
6.70%
Yearly
24.96%
Q1 Forecast
358.86

Roche Holding reported CHF304M in Interest Expense on Debt for its fiscal semester ending in June of 2025.





Interest Expense On Debt Change Date
AbbVie USD 740M 40M Jun/2025
Alcon AG USD 51M 0 Sep/2025
Amgen USD 653M 32M Dec/2025
AstraZeneca USD 484M 181M Dec/2025
Bayer EUR 762M 267M Sep/2025
Biogen USD 72.6M 12.6M Jun/2025
Bristol-Myers Squibb USD 432M 48M Dec/2025
Eli Lilly USD 114.7M 134.3M Sep/2025
Fresenius EUR 81M 5M Sep/2025
Fresenius Medical Care EUR 85M 8.1M Dec/2025
Galapagos EUR 1.72M 940K Sep/2025
Genmab DKK 37M 28M Sep/2025
Gilead Sciences USD 255M 1000K Dec/2025
GlaxoSmithKline GBP 188M 21M Dec/2025
GRIFOLS EUR 141.43M 61.28M Jun/2025
Hikma Pharmaceutical USD 20M 2M Jun/2025
Lonza CHF 84M 14M Jun/2025
Merck EUR 126M 47M Sep/2025
Merck USD 412M 85M Dec/2025
Novartis USD 281M 8M Sep/2025
Orion EUR 600K 600K Sep/2025
Pfizer USD 711M 59M Dec/2025
Philips EUR 109M 31M Dec/2025
Recordati EUR 22.13M 1.43M Dec/2025
Regeneron Pharmaceuticals USD 12.2M 7.1M Dec/2025
Roche Holding CHF 304M 7.5M Jun/2025
Sanofi EUR -25M 252M Dec/2025
UCB EUR 78M 30M Jun/2025